Categories AlphaGraphs, Earnings, Health Care
Biogen (BIIB) Earnings Infographic: Q2 profit, revenue drop but top estimates
Biotechnology firm Biogen Inc. (NASDAQ: BIIB) Thursday said its second-quarter earnings and revenues decreased from last year. The results, however, came in above analysts’ forecast.
Net income attributable to the company was $448.5 million or $2.99 per share in the June quarter, down from last year’s profit of $1.54 billion or $9.59 per share. Adjusted earnings dropped to $5.68 per share from $9.85 per share but topped expectations.
Total revenues decreased 25% year-over-year to $2.78 billion during the three-month period. Analysts had predicted a bigger fall.
Read management/analysts’ comments on Biogen’s Q2 report
Shares of Biogen made strong gains early Thursday following the earnings announcement, after closing the previous session higher.
Prior Performance
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
ACN Earnings: All you need to know about Accenture’s Q2 2023 earnings results
Accenture (NYSE: ACN) reported second quarter 2023 earnings results today. Total revenues increased 5% year-over-year to $15.8 billion. Net income attributable to Accenture plc was $1.52 billion, or $2.39 per
Here’s how FedEx (FDX) plans to soften the impact of volume declines on its business
Shares of FedEx Corporation (NYSE: FDX) stayed green on Wednesday. The stock has gained 26% year-to-date. The company faced a challenging environment in the third quarter of 2023 which took
Walgreens Boots Alliance (WBA) shifts to expansion mode. Will it pay off?
Walgreens Boots Alliance, Inc. (NASDAQ: WBA), a market leader in retail pharmacy, has regularly revised its business model to better align with the transformation the healthcare space is witnessing. Currently,